OBJECTIVE: To present selective endovascular embolization as a therapeutic alternative to surgical ligation in the management of hemorrhage in patients with head and neck squamous cell carcinoma. DESIGN: Retrospective chart review of patients with head and neck cancer and significant hemorrhage who were treated with selective endovascular embolization. SETTING: A university medical center. PATIENTS: A total of 12 patients, aged 26 to 72 years, with 13 episodes of hemorrhage were treated at Oregon Health Sciences University, Portland, between November 1991 and January 1996. INTERVENTION: All patients underwent angiography with selective endovascular embolization at the interventional radiology suite using a combination of endovascular balloons, platinum coils, and microparticles. OUTCOME MEASURES: All charts were reviewed for diagnosis, treatment, factors that may have contributed to hemorrhage, bleeding site, therapeutic measures, control of hemorrhage, postembolization course, complications, and number of hospital days. RESULTS: The cause of the bleeding was tumor in 5 patients, pharyngocutaneous fistula in 4 patients, radiation necrosis in 3 patients, and postoperative complication in 1 patient. Bleeding arose from the common carotid artery in 4 patients, external carotid artery and its branches in 8 patients, and internal jugular vein in 1 patient. Hemorrhage was successfully controlled in all patients; a permanent left-sided hemiplegia and facial weakness developed in 1 patient. There were no recurrences of hemorrhage. All patients were discharged from the hospital. CONCLUSION: Angiography with selective embolization is a safe and effective alternative to surgical ligation for control of hemorrhage in patients with squamous cell carcinoma of the head and neck.
OBJECTIVE: To present selective endovascular embolization as a therapeutic alternative to surgical ligation in the management of hemorrhage in patients with head and neck squamous cell carcinoma. DESIGN: Retrospective chart review of patients with head and neck cancer and significant hemorrhage who were treated with selective endovascular embolization. SETTING: A university medical center. PATIENTS: A total of 12 patients, aged 26 to 72 years, with 13 episodes of hemorrhage were treated at Oregon Health Sciences University, Portland, between November 1991 and January 1996. INTERVENTION: All patients underwent angiography with selective endovascular embolization at the interventional radiology suite using a combination of endovascular balloons, platinum coils, and microparticles. OUTCOME MEASURES: All charts were reviewed for diagnosis, treatment, factors that may have contributed to hemorrhage, bleeding site, therapeutic measures, control of hemorrhage, postembolization course, complications, and number of hospital days. RESULTS: The cause of the bleeding was tumor in 5 patients, pharyngocutaneous fistula in 4 patients, radiation necrosis in 3 patients, and postoperative complication in 1 patient. Bleeding arose from the common carotid artery in 4 patients, external carotid artery and its branches in 8 patients, and internal jugular vein in 1 patient. Hemorrhage was successfully controlled in all patients; a permanent left-sided hemiplegia and facial weakness developed in 1 patient. There were no recurrences of hemorrhage. All patients were discharged from the hospital. CONCLUSION: Angiography with selective embolization is a safe and effective alternative to surgical ligation for control of hemorrhage in patients with squamous cell carcinoma of the head and neck.
Authors: Nathan L Liang; Brian D Guedes; Umamaheswar Duvvuri; Michael J Singh; Rabih A Chaer; Michel S Makaroun; Ulka Sachdev Journal: J Vasc Surg Date: 2016-02-28 Impact factor: 4.268
Authors: Tao Upile; Stefanos Triaridis; Paul Kirkland; Daniel Archer; Adam Searle; Colm Irving; Peter Rhys Evans Journal: Eur Arch Otorhinolaryngol Date: 2005-03-17 Impact factor: 2.503
Authors: Walter S Lesley; John C Chaloupka; John B Weigele; Sundeep Mangla; Mohammad A Dogar Journal: AJNR Am J Neuroradiol Date: 2003-05 Impact factor: 3.825